Treatment With Anakinra, a Recombinant IL-1 Receptor Antagonist, Unlikely to Induce Lasting Remission in Patients With CGD Colitis
暂无分享,去创建一个
S. Holland | C. Zerbe | H. Malech | Nancy Ho | M. Quezado | T. Heller | Lynne Yockey | Amy P. Rump | Beatriz E. Marciano | B. Marciano | Katherine J. Hahn | Janine R. Daub | Samantha Kreuzberg | Samantha A. Kreuzberg
[1] Sarmed S. Sami,et al. A Randomized Comparative Effectiveness Trial of Novel Endoscopic Techniques and Approaches for Barrett’s Esophagus Screening in the Community , 2015, The American Journal of Gastroenterology.
[2] R. Xavier,et al. IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans , 2014, Proceedings of the National Academy of Sciences.
[3] S. Holland,et al. Gastrointestinal Histopathology in Chronic Granulomatous Disease: A Study of 87 Patients , 2013, The American journal of surgical pathology.
[4] R. Fitzgerald,et al. Randomized crossover study comparing efficacy of transnasal endoscopy with that of standard endoscopy to detect Barrett's esophagus. , 2012, Gastrointestinal endoscopy.
[5] S. Holland,et al. Residual NADPH oxidase and survival in chronic granulomatous disease. , 2010, The New England journal of medicine.
[6] J. Orange,et al. Complications of tumor necrosis factor-α blockade in chronic granulomatous disease-related colitis. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] S. Holland,et al. Gastrointestinal involvement in chronic granulomatous disease. , 2004, Pediatrics.
[8] Richard B. Johnston,et al. Chronic Granulomatous Disease: Report on a National Registry of 368 Patients , 2000, Medicine.
[9] R. F. Harvey,et al. A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITY , 1980, The Lancet.